|
Resolution: standard / high Figure 5.
Changes in modified Sharp score in patients with active rheumatoid arthritis despite
methotrexate (MTX) therapy who were given MTX alone or in combination with infliximab
(the Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis With Concomitant Therapy
[ATTRACT] study) [39–41].
Schwartzman et al. Arthritis Res Ther 2004 6(Suppl 2):S3 doi:10.1186/ar1013 |
